Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products

Clinically proven app from Healthimation, LLC, to be paired with Company’s proBEAT non-invasive CGM system solution to offer convenient and effective management of pre-diabetes and Type 2 diabetes

LOUGHBOROUGH, Sept. 21, 2020 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has licensed the rights to Healthimation, LLC’s mobile application based digital program, a well-validated and award-winning 12-week program to help patients manage their weight and pre-diabetes or early diabetes conditions. The program is intended to be combined with the company’s proBEAT™ non-invasive patch CGM (continuous glucose monitor) for an enhanced behavioral change experience.

Developed at a major diabetes center in the U.S. over more than 15 years, the digital program curriculum implements the most advanced approach to nutrition, exercise, and behavioral

Read More